欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3178/002
药品名称Bortezomib Glenmark 3,5 mg
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Glenmark Pharmaceuticals s.r.o., City Tower, Hvezdova 1716/2b, 140 78 Prague 4, Czech Republic
参考成员国 - 产品名称Netherlands (NL)
Bortezomib Glenmark 3,5 mg, poeder voor oplossing voor injectie
互认成员国 - 产品名称
    • Poland (PL)
      Bortezomib Glenmark
    • Slovakia (SK)
      Bortezomib Glenmark 3,5 mg
许可日期2015/05/27
最近更新日期2024/08/02
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase